These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22551448)

  • 1. Visceral leishmaniasis in hematopoietic stem cell transplantation.
    Bautista G; Ramos A; Gil S
    Transpl Int; 2012 Jul; 25(7):e83-5. PubMed ID: 22551448
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation.
    Agteresch HJ; van 't Veer MB; Cornelissen JJ; Sluiters JF
    Bone Marrow Transplant; 2007 Aug; 40(4):391-3. PubMed ID: 17572716
    [No Abstract]   [Full Text] [Related]  

  • 3. Visceral leishmaniasis in HIV-infected patients.
    del Mar Sanz M; Rubio R; Casillas A; Guijarro C; Costa JR; Martinez R; de Dios Garcia J
    AIDS; 1991 Oct; 5(10):1272-4. PubMed ID: 1786161
    [No Abstract]   [Full Text] [Related]  

  • 4. Visceral leishmaniasis among liver transplant recipients: an overview.
    Campos-Varela I; Len O; Castells L; Tallada N; Ribera E; Dopazo C; Vargas V; Gavaldà J; Charco R
    Liver Transpl; 2008 Dec; 14(12):1816-9. PubMed ID: 19025932
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis (kala-azar) in solid organ transplantation: report of five cases and review.
    Hernández-Pérez J; Yebra-Bango M; Jiménez-Martínez E; Sanz-Moreno C; Cuervas-Mons V; Alonso Pulpón L; Ramos-Martínez A; Fernández-Fernández J
    Clin Infect Dis; 1999 Oct; 29(4):918-21. PubMed ID: 10589910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients.
    Sirvent-von Bueltzingsloewen A; Marty P; Rosenthal E; Delaunay P; Allieri-Rosenthal A; Gratecos N; Cassuto JP
    Bone Marrow Transplant; 2004 Mar; 33(6):667-8. PubMed ID: 14730334
    [No Abstract]   [Full Text] [Related]  

  • 7. Is leishmaniasis an "unusual suspect" of infection in allogeneic transplantation?
    Komitopoulou A; Tzenou T; Baltadakis J; Apostolidis J; Karakasis D; Harhalakis N
    Transpl Infect Dis; 2014 Dec; 16(6):1012-8. PubMed ID: 25412926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
    Avery RK; Marty FM; Strasfeld L; Lee I; Arrieta A; Chou S; Tatarowicz W; Villano S
    Transpl Infect Dis; 2010 Dec; 12(6):489-96. PubMed ID: 20682012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis reactivation in transplant patients: a minireview with report of a new case.
    Postorino MC; Bellantoni M; Catalano C; Caridi G; De Rosa M; Seck S; Enia G
    J Nephrol; 2011; 24(4):530-4. PubMed ID: 21607915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors.
    Sabé N; González-Costello J; Rama I; Niubó J; Bodro M; Roca J; Cruzado JM; Manito N; Carratalà J
    Transpl Int; 2012 Jul; 25(7):e78-82. PubMed ID: 22574951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem cell transplant recipients.
    Tormo N; Solano C; Benet I; Clari MA; Nieto J; de la Cámara R; López J; López-Aldeguer N; Hernández-Boluda JC; Remigia MJ; Garcia-Noblejas A; Gimeno C; Navarro D
    Bone Marrow Transplant; 2010 Mar; 45(3):543-9. PubMed ID: 19617905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic stem cell transplant recipients].
    Torre-Cisneros J; Caston-Osorio JJ; Martín C; Rivero A; Doblas A; Rojas R; Gómez P; Martínez F; Torres A
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):6-12. PubMed ID: 19409666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yanada M; Yamamoto K; Emi N; Naoe T; Suzuki R; Taji H; Iida H; Shimokawa T; Kohno A; Mizuta S; Maruyama F; Wakita A; Kitaori K; Yano K; Hamaguchi M; Hamajima N; Morishima Y; Kodera Y; Sao H; Morishita Y
    Bone Marrow Transplant; 2003 Oct; 32(8):801-7. PubMed ID: 14520425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil.
    Oliveira RA; Silva LS; Carvalho VP; Coutinho AF; Pinheiro FG; Lima CG; Leandro JE; Silva GB; Daher EF
    Transpl Infect Dis; 2008 Oct; 10(5):364-8. PubMed ID: 18507750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
    Harzallah K; Belhadj R; Jemli B; Haloues M; Berraies N; Gargouri S; Hmida J; Battikh R; Manaa J
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):105-8. PubMed ID: 20061702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral leishmaniasis in the early post-transplant period after kidney transplantation: clinical features and therapeutic management.
    Veroux M; Corona D; Giuffrida G; Cacopardo B; Sinagra N; Tallarita T; Giaquinta A; Zerbo D; Veroux PF
    Transpl Infect Dis; 2010 Oct; 12(5):387-91. PubMed ID: 20534033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytomegalovirus infection and immunosuppressant treatment in allogeneic hematopoietic stem cell transplantation recipients].
    Xie W; Zhang X; Peng G; Yi B; Liu W; Zhong B; Jian Z; Fan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 35(11):1162-6. PubMed ID: 21131738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral leishmaniasis in kidney transplantation: report of one case.
    Salva M; Fernandez Fernandez J; Berisa F; Enriquez R; Sanz Moreno C; Sanz Guajardo D; Gallego JL; Hernandez J; Botella J
    Clin Transpl; 1986; ():134. PubMed ID: 3154385
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation.
    Mori T; Okamoto S; Watanabe R; Yajima T; Iwao Y; Yamazaki R; Nakazato T; Sato N; Iguchi T; Nagayama H; Takayama N; Hibi T; Ikeda Y
    Bone Marrow Transplant; 2002 May; 29(9):777-82. PubMed ID: 12040476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.